IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.270
-0.030 (-2.31%)
Aug 13, 2025, 4:00 PM - Market closed
IGM Biosciences Market Cap
IGM Biosciences has a market cap or net worth of $76.57 million as of August 14, 2025. Its market cap has decreased by -88.90% in one year.
Market Cap
76.57M
Enterprise Value
-27.73M
1-Year Change
-88.90%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since August 14, 2020, IGM Biosciences's market cap has decreased from $1.59B to $76.57M, a decrease of -95.19%. That is a compound annual growth rate of -45.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 79.59M | -78.70% |
| Dec 31, 2024 | 373.70M | -24.84% |
| Dec 29, 2023 | 497.18M | -33.93% |
| Dec 30, 2022 | 752.55M | -24.18% |
| Dec 31, 2021 | 992.49M | -66.27% |
| Dec 31, 2020 | 2.94B | 84.93% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 576.80B |
| Johnson & Johnson | 419.12B |
| AbbVie | 348.54B |
| UnitedHealth Group | 231.21B |
| Abbott Laboratories | 228.68B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |